RecruitingNot Applicable

Connect-Home: Alzheimer's Disease and Related Dementias

United States360 participantsStarted 2025-04-04

Plain-language summary

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients: * Ability to speak English * Goal of discharge to home, assisted living, or long-term care * Diagnosis of dementia * Having a caregiver willing to participate Caregivers: * Ability to speak English * Legally authorized representative (LAR) who also provides support for the person with ADRD Inclusion criteria for SNFs: * Location within 120 miles of UNC-Chapel Hill * Admission of at least 75 SNF patients per year Exclusion Criteria: Patients: * Planned hospital readmission for procedures or treatments within 30 days post enrollment. Caregivers: * LAR is a court-appointed guardian.

What they're measuring

Caregiver Strain

Timeframe: 30 days after discharge from SNF

Patient Neuropsychiatric Symptoms

Timeframe: 30 days after discharge from SNF

Trial details

NCT IDNCT06840587

SponsorUniversity of North Carolina, Chapel Hill

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-06-30

Contact for this trial

Molly Lynch, MS

9198438874 molly_lynch@unc.edu

View on ClinicalTrials.gov More Alzheimer Disease trials